Investigating expectation and reward in human opioid addiction with [11C]raclopride PET

Addiction Biology

Volumn 19, Issue 6, 2014, Pages 1032-1040

  Watson, Ben J ^a   Taylor, Lindsay G ^a   Reid, Alastair G ^b   Wilson, Sue J ^c   Stokes, Paul R ^c   Brooks, David J ^c   Myers, James F ^a   Turkheimer, Federico E ^d   Nutt, David J ^c   Lingford Hughes, Anne R ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b OXFORD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Addiction; dopamine; expectation; heroin; opioid; PET

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; DOPAMINE; METHADONE; RACLOPRIDE C 11; DOPAMINE RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; RACLOPRIDE;

ARTICLE; BOLUS INJECTION; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DRUG BLOOD LEVEL; EXPECTATION; METHADONE TREATMENT; OPIATE ADDICTION; OXYGEN SATURATION; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; REWARD; SACCADIC EYE MOVEMENT; SMOKING; STEADY STATE; ADULT; AGED; ANTICIPATION; DRUG EFFECTS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OPIOID-RELATED DISORDERS; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SCINTISCANNING; YOUNG ADULT;

ADULT; AGED; ANALGESICS, OPIOID; ANTICIPATION, PSYCHOLOGICAL; BUPRENORPHINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; REWARD; YOUNG ADULT;

EID: 84916228589     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12073     Document Type: Article

References (50)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders DSM-IV, 4th edn. Washington, DC: American Psychiatric Association.
2. Badiani A, Belin D, Epstein D, Calu D, Shaham Y, (2011) Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12: 685-700.
3. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J, (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
4. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A, (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49: 226-231.
5. Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC, (1997) Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17: 437-447.
6. Clemens JA, Sawyer BD, (1974) Evidence that methadone stimulates prolactin release by dopamine receptor blockade. Endocr Res Commun 1: 373-378.
7. Daglish MR, Williams TM, Wilson SJ, Taylor LG, Eap CB, Augsburger M, Giroud C, Brooks DJ, Myles JS, Grasby P, Lingford-Hughes AR, Nutt DJ, (2008) Brain dopamine response in human opioid addiction. Br J Psychiatry 193: 65-72.
8. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW, (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270.
9. Egerton A, Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, Cunningham VJ, Grasby PM, (2009) The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci Biobehav Rev 33: 1109-1132.
10. Everitt BJ, Robbins TW, (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489.
11. de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ, (2002) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136: 359-363.
12. Gerrits MA, Van Ree JM, (1996) Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats. Brain Res 713: 114-124.
13. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ, (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6: 279-287.
14. Hagelberg N, Kajander JK, Någren K, Hinkka S, Hietala J, Scheinin H, (2002) Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse 45: 25-30.
15. Haltia LT, Rinne JO, Helin S, Parkkola R, Någren K, Kaasinen V, (2008) Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse 62: 682-688.
16. Kaasinen V, Aalto S, Någren K, Rinne JO, (2004) Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci 19: 2352-2356.
17. Lammertsma AA, Hume SP, (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4 (3 Pt 1): 153-158.
18. Laruelle M, (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20: 423-451.
19. Law F, Bailey J, Allen D, Melichar J, Myles J, Mitcheson M, Lewis J, Nutt D, (1997) The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting. Addict Biol 2: 191-200.
20. Leyton M, (2007) Conditioned and sensitized responses to stimulant drugs in humans. Prog Neuropsychopharmacol Biol Psychiatry 31: 1601-1613.
21. Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, de la Fuente-Fernández R, Phillips AG, Stoessl AJ, (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67: 857-865.
22. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A, (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58: 779-786.
23. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M, (2007) Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164: 622-629.
24. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, Cook S, Broft A, Van Heertum R, Comer SD, (2012) Deficits in dopamine d(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 71: 192-198.
25. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M, (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300.
26. McNamara R, Dalley JW, Robbins TW, Everitt BJ, Belin D, (2010) Trait-like impulsivity does not predict escalation of heroin self-administration in the rat. Psychopharmacology (Berl) 212: 453-464.
27. 11C]raclopride PET study. Synapse 61: 637-645.
28. Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM, (2006) Correction of head movement on PET studies: comparison of methods. J Nucl Med 47: 1936-1944.
29. Paterson S, Cordero R, Burlinson S, (2004) Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 813: 323-330.
30. Pettit HO, Ettenberg A, Bloom FE, Koob GF, (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84: 167-173.
31. Sasame HA, Perez-Cruet J, Di Chiara G, Tagliamonte A, Tagliamonte P, Gessa GL, (1972) Evidence that methadone blocks dopamine receptors in the brain. J Neurochem 19: 1953-1957.
32. Schultz W, (2010) Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 6: 24.
33. Schultz W, Dayan P, Montague PR, (1997) A neural substrate of prediction and reward. Science 275: 1593-1599.
34. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK, (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55: 325-336.
35. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G, (1983) Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
36. Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G, (2011) Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study. Biol Psychiatry 70: 770-776.
37. Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, Nutt DJ, Mehta MA, (2010) Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage 52: 1521-1527.
38. Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM, (2009) Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage 48: 186-190.
39. Tamarkin NR, Goodwin FK, Axelrod J, (1970) Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci I 9: 1397-1408.
40. Van Ree JM, Ramsey N, (1987) The dopamine hypothesis of opiate reward challenged. Eur J Pharmacol 134: 239-243.
41. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM, (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43: 181-187.
42. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N, (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833.
43. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A 108: 15037-15042.
44. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R, (2010) Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays 32: 748-755.
45. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM, (2003) Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 23: 11461-11468.
46. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C, (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
47. Watabe H, Endres CJ, Breier A, Schmall B, Eckelman WC, Carson RE, (2000) Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. J Nucl Med 41: 522-530.
48. Wilson SJ, Glue P, Ball D, Nutt DJ, (1993) Saccadic eye movement parameters in normal subjects. Electroencephalogr Clin Neurophysiol 86: 69-74.
49. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasic JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED, (2006) Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31: 2716-2727.
50. Zijlstra F, Booij J, van den Brink W, Franken IH, (2008) Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol 18: 262-270.